NEWS RELEASE: Trelleborg Medical Solutions Announces Expanded Capabilities for Customers Through its Innovation Center
[Image courtesy of Trelleborg]
Trelleborg created the Innovation Center to accelerate customers’ time to market, reduce the production cost of parts already in market and improve the transition from design to serial production. With increased capabilities, the Innovation Center is a dedicated space with personnel possessing decades of combined experience and expertise in all areas of medical device component manufacturing. It enables healthcare and medical customers to work with design, materials, and quality experts throughout the entire life cycle of a project.
Chris Tellers, Global Technology Director, Trelleborg Medical Solutions, says: “For healthcare and medical innovators looking to create high-performing products and measurably reduce go-to-market timelines, our team at the Innovation Center can create samples in days, enabling multiple design iterations to be tested to confirm effective production and rapid scale up.
“Engineers and product innovators get direct access to some of the best minds in materials science, prototyping, tooling and design for manufacturability, plus proven processes for improving critical outcomes in development and manufacturing. Simply bring us your product design goals and we will work together to create highly differentiated products and get them to market faster. You can visit our experts in-person or engage in highly personalized digital experiences.
“We take a collaborative approach to help customers optimize their designs and discover how they can be realized. We have decades of experience designing and manufacturing advanced silicone solutions and now we can offer customers expertise in thermoplastic molding and manufacturing. We look at customers’ complex designs and quickly create prototypes and tooling that help them achieve their goals.”
The Innovation Center comprises several core competencies critical to medical device and pharmaceutical component development, including design, consultation, toolmaking, prototyping, high-precision machining, silicone molding, thermoplastic molding, automation, assembly and secondary operations.
By using Trelleborg’s manufacturing facilities, customers have access to raw material traceability, Class 7 cleanrooms and established validation processes. These facilities are ISO 13485:2016 and ISO 9001 certified and meet the requirements of the Food and Drug Administration, European Medical Device Regulation and global water regulation requirements. Trelleborg leverages its manufacturing expertise and long-term vision to transform customer ideas from design to global, long-term production, quickly and affordably.
To learn more about the Innovation Center, visit: trelleborg.com/en/medical/development-manufacturing-services/innovation-center
About Trelleborg Medical Solutions and Trelleborg Group
Trelleborg Medical Solutions partners with the world’s leading medical device and biopharmaceutical companies, collaborating from concept to commercialization to bring to market impactful solutions that improve patient quality of life. It leverages decades of design and manufacturing experience, in-depth knowledge of polymer materials and a deep understanding of customer applications and end-use environments to deliver pioneering, engineered solutions for transformative health technologies. Utilizing its global quality system and engineering and manufacturing network, the company is a production partner of choice for medical device and biopharmaceutical companies. www.trelleborg.com/medical
Trelleborg is a world leader in engineered polymer solutions that protect critical applications in demanding environments. Its innovative solutions accelerate performance for customers in a sustainable way. In 2023, the Trelleborg Group had annual sales of approximately SEK 34 billion in around 40 countries. The Group comprises three business areas: Trelleborg Industrial Solutions, Trelleborg Sealing Solutions and Trelleborg Medical Solutions. The Trelleborg share has been listed on the Stock Exchange since 1964 and is listed on Nasdaq Stockholm, Large Cap. www.trelleborg.com
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
